Presented
by

Presented by Oxford Global

Discover PLUS Pass

All Cell Content

Bringing you the latest research surrounding the safety, efficacy and characterisation of cell & gene therapies, targeted approaches for cell line development, optimised cell media techniques, and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Industry Spotlight
In Conversation With... Marta Barisa, Senior Research Fellow at UCL
Here, we speak to Marta Barisa, Senior Research Fellow at UCL, about switchable CAR-Ts and therapies for solid tumours.
Edited by Ben Norris |
30 October 2023
Cell Therapy Development
Industry Spotlight
Revolutionising Biomedicine: How AI Techniques and Applications enhance 3D Modeling in Cell & Gene Therapy and Drug Development
Discover the transformative role of AI in the world of biotechnology. Dive deep into its synergy with 3D modeling, revealing groundbreaking advancements in cell & gene therapy and faster, more efficient drug development cycles.
Edited by Guillaume Alonso |
09 October 2023
Gene Therapy Development, Cell Therapy Development
Industry Spotlight
How Adaptimmune’s T-Cell Therapy Development Pipeline Became a Commercialisation Success Story
Adaptimmune has developed from a strategic collaboration with GSK and embarked on a highly successful journey towards developing cancer immunotherapy treatments.
Edited by Ben Norris |
28 September 2023
Cell Therapy Development
Whitepaper
Fast Encapsulation of Cells and DNA for Downstream Analysis
19 September 2023
Cell Therapy Development
Whitepaper
Droplet Compatibility of Xdrop DE20 and DE50 Production
19 September 2023
Cell Therapy Development
Whitepaper
Technical Note for the Viability of DE20 and DE50 Droplets
19 September 2023
Cell Therapy Development
Whitepaper
Retrieving Potent IFN-y Secretors via a Single-Cell Format Workflow
19 September 2023
Cell Therapy Development
Industry Spotlight
BrainStorm Hope to Mimic Biogen’s Accelerated Approval of ALS Drug
The biotech company BrainStorm is seeking regulatory approval from the FDA for its cell therapy, NurOwn, which has been developed for the treatment of ALS.
Edited by Ben Norris |
11 July 2023
Cell Therapy Development
Whitepaper
Biosafety Services - Health Inspired, Quality Driven
10 May 2023
Cell Therapy Development
Video Content
Video Q&A
Regulation and Policy Interview with Scott Burger, Principal of Advanced Cell and Gene Therapy
Scott Burger, Principal of Advanced Cell and Gene Therapy, discusses some of the recent trends in regulation and policy surrounding cell and gene therapy development.
Edited by Ben Norris |
10 March 2023
Cell Therapy Development

Search by Keyword

Filter by Subject Area

Cell Series – Subject

Filter by Content Type

Resource Formats (incl. Industry Spotlight)

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.